Evidence map›Paper›PMID 32284329›Full record

ArticleThe Journal of biological chemistry2020

Functional diversity between HSP70 paralogs caused by variable interactions with specific co-chaperones.

Despina Serlidaki, Maria A W H van Waarde, Lukas Rohland, Anne S Wentink, Suzanne L Dekker, Maarten J Kamphuis, Jeffrey M Boertien, Jeanette F Brunsting, Nadinath B Nillegoda, Bernd Bukau and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Mechanisms and regulation of the Hsp70 chaperone network.Nature reviews. Molecular cell biology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. DnaJs are enriched in tau regulators.International journal of biological macromolecules · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 3 countries.

Despina SerlidakiDepartment of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, 9713 AV Groningen, The Netherlands.
Maria A W H van WaardeDepartment of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, 9713 AV Groningen, The Netherlands.
Lukas RohlandCenter for Molecular Biology of the University of Heidelberg and the German Cancer Research Center, 69120 Heidelberg, Germany.
Anne S WentinkCenter for Molecular Biology of the University of Heidelberg and the German Cancer Research Center, 69120 Heidelberg, Germany.
Suzanne L DekkerDepartment of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, 9713 AV Groningen, The Netherlands.
Maarten J KamphuisDepartment of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, 9713 AV Groningen, The Netherlands.
Jeffrey M BoertienDepartment of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, 9713 AV Groningen, The Netherlands.
Jeanette F BrunstingDepartment of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, 9713 AV Groningen, The Netherlands.
Nadinath B NillegodaCenter for Molecular Biology of the University of Heidelberg and the German Cancer Research Center, 69120 Heidelberg, Germany; Australian Regenerative Medicine Institute, Monash University, Clayton, Victoria 3800, Australia.
Bernd BukauCenter for Molecular Biology of the University of Heidelberg and the German Cancer Research Center, 69120 Heidelberg, Germany.
Matthias P MayerCenter for Molecular Biology of the University of Heidelberg and the German Cancer Research Center, 69120 Heidelberg, Germany.
Harm H KampingaDepartment of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, 9713 AV Groningen, The Netherlands. Electronic address: h.h.kampinga@umcg.nl.
Steven BerginkDepartment of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, 9713 AV Groningen, The Netherlands. Electronic address: s.bergink@umcg.nl.
University Medical Center Groningen · NLGerman Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heat shock protein 70 (HSP70) chaperones play a central role in protein quality control and are crucial for many cellular processes, including protein folding, degradation, and disaggregation. Human HSP70s compose a family of 13 members that carry out their functions with the aid of even larger families of co-chaperones. A delicate interplay between HSP70s and co-chaperone recruitment is thought to determine substrate fate, yet it has been generally assumed that all Hsp70 paralogs have similar activities and are largely functionally redundant. However, here we found that when expressed in human cells, two highly homologous HSP70s, HSPA1A and HSPA1L, have opposing effects on cellular handling of various substrates. For example, HSPA1A reduced aggregation of the amyotrophic lateral sclerosis-associated protein variant superoxide dismutase 1 (SOD1)-A4V, whereas HSPA1L enhanced its aggregation. Intriguingly, variations in the substrate-binding domain of these HSP70s did not play a role in this difference. Instead, we observed that substrate fate is determined by differential interactions of the HSP70s with co-chaperones. Whereas most co-chaperones bound equally well to these two HSP70s, Hsp70/Hsp90-organizing protein (HOP) preferentially bound to HSPA1L, and the Hsp110 nucleotide-exchange factor HSPH2 preferred HSPA1A. The role of HSPH2 was especially crucial for the HSPA1A-mediated reduction in SOD1-A4V aggregation. These findings reveal a remarkable functional diversity at the level of the cellular HSP70s and indicate that this diversity is defined by their affinities for specific co-chaperones such as HSPH2.

Indexed as

Protein Aggregation, PathologicalAmino Acid SubstitutionCell Line, TumorHEK293 CellsHomeodomain ProteinsHSP110 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsHumansMutation, MissenseSuperoxide Dismutase-1Tumor Suppressor ProteinsHomeodomain ProteinsHOPX protein, humanHSP110 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsHSPA1A protein, humanHSPA1L protein, humanHSPA4 protein, humanSOD1 protein, humanSuperoxide Dismutase-1Tumor Suppressor Proteins70 kilodalton heat shock protein (Hsp70)amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease)heat shock protein (HSP)Hsp110HSPA4HSPH2protein foldingproteostasissuperoxide dismutase (SOD)

Identifiers

PMID32284329
PMCPMC7247296
OpenAlexW3015589319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.